DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS
  1. Home
  2. BMFRP Research Highlights/News
  3. 2015 Bone Marrow Failure Research Program

NEWS RELEASE

Updated: February 18, 2015
Released: February 11, 2015

Defense Health Program
Department of Defense Bone Marrow Failure Research Program
Funding Opportunities for Fiscal Year 2015 (FY15)

The FY15 Defense Appropriations Act provides $3.2 million to the Department of Defense Bone Marrow Failure Research Program (BMFRP) to support innovative research committed to advancing the understanding of inherited and acquired bone marrow failure diseases. As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency, Research, Development, and Acquisition (DHA RDA) Directorate manages and executes the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The executing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).

The BMFRP is providing the information in this pre-announcement to allow investigators time to plan and develop applications. FY15 BMFRP Program Announcement and General Application Instructions for the following award mechanism are anticipated to be posted on the Grants.gov website in March 2015. Pre-application and application deadlines will be available when the Program Announcement is released. This pre-announcement should not be construed as an obligation by the government. Funding is contingent on receipt of appropriations.

Award Mechanism Eligibility Key Mechanism Elements Funding
Idea Development Award Investigators at or above the level of Assistant Professor (or equivalent)
  • Supports innovative ideas and high-impact approaches based on scientifically sound evidence in order to move towards the vision to understand and cure BMF.
  • Strong BMF research team.
  • Early career investigators are encouraged to apply.
  • May include relevant preliminary data.
  • Clinical trials will not be supported.
  • Maximum funding of $360,000 in direct costs (plus indirect costs)
  • Period of performance not to exceed 2 years

All applications must conform to the final Program Announcement and General Application Instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for the award mechanism will also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

A pre-application is required and must be submitted through the CDMRP electronic Biomedical Research Application Portal (eBRAP) website (https://eBRAP.org) prior to the pre-application deadline. Applications must be submitted through the federal government's single-entry portal, Grants.gov. Submission deadlines are not available until the Program Announcement is released. Requests for email notification of the Program Announcement release may be sent to help@eBRAP.org. Email notifications of funding opportunities are sent as a courtesy and should not be used as a sole source of notification; applicants should monitor Grants.gov for official postings of funding opportunities.

For more information about the BMFRP or other CDMRP-administered programs, please visit the CDMRP website (https://CDMRP.HEALTH.MIL).

Point of Contact: